Hypertansion
Conditions
Keywords
generative artificial intelligence, medication adherence, hypertansion, self efficacy, blood pressure
Brief summary
This study evaluates whether generative artificial intelligence-supported personalized education can improve hypertension knowledge and medication adherence in adults with hypertension compared with standard printed educational material. A total of 88 adults with hypertension are included in the study. Participants are assigned to either an intervention group or a control group. The control group receives a printed hypertension education booklet. The intervention group receives personalized educational content prepared using generative artificial intelligence based on individual characteristics and needs, together with weekly WhatsApp or SMS messages, voice messages, and brief telephone follow-up. The intervention lasts four weeks, and final assessments are performed in the fifth week. Hypertension knowledge, medication adherence self-efficacy, and blood pressure are assessed before and after the intervention. It is expected that personalized education will improve hypertension knowledge and medication adherence compared with printed education.
Interventions
Participants receive standard hypertension education including medication-related information and a printed hypertension education booklet developed based on expert recommendations.
Participants receive personalized hypertension education generated using generative artificial intelligence based on individual characteristics, needs, baseline information, and standardized hypertension education content. The intervention is delivered over four weeks through weekly WhatsApp or SMS messages and voice messages. Brief structured telephone follow-up is provided in the first and fourth weeks.
Sponsors
Study design
Intervention model description
Participants are assigned nonrandomly to two parallel groups in a 1:1 ratio. The control group receives standard printed hypertension education, while the intervention group receives generative artificial intelligence-supported personalized education in addition to the printed material. Both groups are assessed at baseline and again in the fifth week.
Eligibility
Inclusion criteria
* Voluntary agreement to participate in the study * Diagnosis of hypertension * Use of antihypertensive medication for at least 6 months * Medication adherence self-efficacy score of 26 or lower * Age 18 years or older * Ability to read and write in Turkish * General health status adequate for communication * Ability to read SMS messages and use WhatsApp
Exclusion criteria
* Withdrawal from the study after enrollment * Inability to be reached by telephone during the follow-up period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean Change From Baseline in Medication Adherence Self-Efficacy Scale-Short Form (MASES-SF) Total Score at Week 5 | Baseline and Week 5 | Medication adherence self-efficacy will be assessed using the 13-item Medication Adherence Self-Efficacy Scale-Short Form (MASES-SF). Each item is scored from 1 (not at all sure) to 4 (very sure), resulting in a total score ranging from 13 to 52. Higher scores indicate greater self-efficacy for adhering to antihypertensive medication. The change in total score from baseline to Week 5 will be evaluated. |
| Mean Change From Baseline in Hypertension Knowledge-Level Scale (HK-LS) Total Score at Week 5 | Baseline and Week 5 | Hypertension knowledge will be assessed using the 22-item Hypertension Knowledge-Level Scale (HK-LS). The scale includes six domains: definition, medical treatment, medication adherence, lifestyle, diet, and complications. Responses are recorded as true, false, or do not know, and each correct response receives 1 point. Higher scores indicate greater hypertension knowledge, and a score of 16 or above indicates a high level of hypertension knowledge. The change in total score from baseline to Week 5 will be evaluated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mean Change From Baseline in Systolic Blood Pressure at Week 5 | Baseline and Week 5 | Systolic blood pressure will be measured in mmHg at baseline and Week 5. The change in systolic blood pressure from baseline to Week 5 will be evaluated. |
| Mean Change From Baseline in Diastolic Blood Pressure at Week 5 | Baseline and Week 5 | Diastolic blood pressure will be measured in mmHg at baseline and Week 5. The change in diastolic blood pressure from baseline to Week 5 will be evaluated. |
Countries
Turkey (Türkiye)
Contacts
Akdeniz University